After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.
UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.
Chronic obstructive pulmonary disease ... to death in people with COPD who used fall-risk increasing drugs to those with COPD who did not use these drugs. We found that the chance of a person ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
This precision imaging approach to enrich AER-01-002 with mucus plug-high, moderate to severe COPD patients maximizes the ...